A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome*-Reference-Cited by-同舟云学术

A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome*

Published:2008-03 Issue:3 Volume:36 Page:782-788
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Morris Peter E.,Papadakos Peter,Russell James A.,Wunderink Richard,Schuster Daniel P.,Truwit Jonathon D.,Vincent Jean-Louis,Bernard Gordon R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference27 articles.

1. Incidence and Outcomes of Acute Lung Injury

2. Ventilatory Management of Acute Lung Injury and Acute Respiratory Distress Syndrome

3. Superoxide Anion, the Main Species of ROS in the Development of ARDS Induced by Oleic Acid

4. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury;International Journal of Clinical Practice;2024-02-06

2. Sample size estimation in clinical trials using ventilator-free days as the primary outcome: a systematic review;Critical Care;2023-08-01

3. Personalized medicine targeting different ARDS phenotypes: The future of pharmacotherapy for ARDS?;Expert Review of Respiratory Medicine;2023-01-02

4. The Impact of Sample Size Misestimations on the Interpretation of ARDS Trials;Chest;2022-11

5. Mitochondria and their potential role in acute lung injury (Review);Experimental and Therapeutic Medicine;2022-06-01